Published in N Engl J Med on January 07, 1999
Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ (2001) 4.24
American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med (2001) 1.70
Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health (2006) 1.51
Closing the Black-White gap in birth outcomes: a life-course approach. Ethn Dis (2010) 1.43
Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J Clin Invest (2003) 1.34
Thrombophilia and pregnancy. Reprod Biol Endocrinol (2003) 1.16
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med (2010) 1.05
Mice deficient in heparan sulfate 3-O-sulfotransferase-1: normal hemostasis with unexpected perinatal phenotypes. Glycoconj J (2003) 1.03
Maternal near miss and death among women with severe hypertensive disorders: a Brazilian multicenter surveillance study. Reprod Health (2014) 0.97
Inherited thrombophilia and pregnancy associated venous thromboembolism. BMJ (2007) 0.96
Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol (2002) 0.96
Case reports: heritable thrombophilia associated with deep venous thrombosis after shoulder arthroscopy. Clin Orthop Relat Res (2009) 0.96
Utility of testing for factor V Leiden. Blood Transfus (2012) 0.96
Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure. J Assist Reprod Genet (2013) 0.94
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes. Thromb Res (2009) 0.92
Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels. Croat Med J (2006) 0.91
The possible role of hyperhomocysteinemia on IVF outcome. J Assist Reprod Genet (2007) 0.91
Associations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption. Am J Obstet Gynecol (2007) 0.90
Risk of subsequent thromboembolism for patients with pre-eclampsia. BMJ (2003) 0.88
Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol (2004) 0.88
Thrombophilia in pregnancy. J Clin Pathol (2000) 0.87
The effect of factor V Leiden carriage on maternal and fetal health. CMAJ (2002) 0.86
Futility of testing for factor V Leiden. Blood Transfus (2012) 0.84
Genome-wide and candidate gene association studies of placental abruption. Int J Mol Epidemiol Genet (2013) 0.84
The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth (2006) 0.83
Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. J Mol Diagn (2003) 0.83
Thrombophilias and adverse outcomes of pregnancy--what should a clinician do? N Engl J Med (1999) 0.83
PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One (2011) 0.83
Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy (2014) 0.81
Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis. PLoS One (2014) 0.81
Recurrent IVF failure and hereditary thrombophilia. Iran J Reprod Med (2014) 0.81
Hereditary thrombophilic risk factors for recurrent pregnancy loss. J Community Genet (2010) 0.79
Evaluation of genes involved in limb development, angiogenesis, and coagulation as risk factors for congenital limb deficiencies. Am J Med Genet A (2012) 0.79
Methylenetetrahydrofolate Reductase C677T Polymorphism and Recurrent Pregnancy Loss Risk in Asian Population: A Meta-analysis. Indian J Clin Biochem (2016) 0.78
Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women. J Pregnancy (2011) 0.78
Lack of Association between Recurrent Pregnancy Loss and Inherited Thrombophilia in a Group of Colombian Patients. Thrombosis (2012) 0.78
A genome-wide association study of variations in maternal cardiometabolic genes and risk of placental abruption. Int J Mol Epidemiol Genet (2012) 0.78
Short-term outcome of patients with preeclampsia. Vasc Health Risk Manag (2013) 0.78
The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities. Trans Am Clin Climatol Assoc (2001) 0.78
Placental lesions associated with acute atherosis. J Matern Fetal Neonatal Med (2014) 0.77
Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss. Iran J Reprod Med (2013) 0.77
Association of Prothrombin (A20210G) and Factor V Leiden (A506G) with Recurrent Pregnancy Loss. Maedica (Buchar) (2012) 0.77
Genotyping analysis for the 46 C/T polymorphism of coagulation factor XII and the involvement of factor XII activity in patients with recurrent pregnancy loss. PLoS One (2014) 0.76
Association of preterm birth with brain malformations. Pediatr Res (2009) 0.76
Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for preeclampsia: a meta-analysis. J Assist Reprod Genet (2015) 0.76
APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women. BMC Pregnancy Childbirth (2010) 0.76
Thrombophilia Associated with Anti-DFS70 Autoantibodies. PLoS One (2015) 0.76
The cost-benefit ratio of screening pregnant women for thrombophilia. Blood Transfus (2007) 0.75
Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption. Open Access Maced J Med Sci (2015) 0.75
Hereditary haemorrhagic telangiectasia and genetic thrombophilia. Eur J Hum Genet (2009) 0.75
Intrauterine upper limb ischemia: an unusual presentation of fetal thrombophilia-a case report and review of the literature. Case Rep Pediatr (2013) 0.75
Thrombophilia and damage of kidney during pregnancy. J Prenat Med (2011) 0.75
The effect of maternal thrombophilia on placental abruption: Histologic correlates. J Matern Fetal Neonatal Med (2009) 0.75
Impact of smoking during pregnancy on functional coagulation testing. Am J Perinatol (2011) 0.75
Prophylactic Low Molecular Weight Heparin Improving Perinatal Outcome in Non-thrombophilic Placental-Mediated Complications. J Obstet Gynaecol India (2015) 0.75
Recurrent pregnancy loss in a subject with heterozygote factor V Leiden mutation; a case report. Rep Biochem Mol Biol (2014) 0.75
Low-molecular-weight heparins during pregnancy. Can Fam Physician (2005) 0.75
Folic Acid Supplementation in Pregnancy and the Risk of Pre-Eclampsia-A Cohort Study. PLoS One (2016) 0.75
Thrombophilias and pregnancy complications: a case-control study. Int J Biomed Sci (2007) 0.75
Postpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature. Thromb J (2010) 0.75
Evaluation of selected thrombotic factors among pregnant women with preeclampsia and normal pregnant women. Iran J Reprod Med (2014) 0.75
The impact of molecular medicine upon early cardiovascular drug development. Br J Clin Pharmacol (2000) 0.75
Pregnancy, pregnancy loss, and the risk of cardiovascular disease in Chinese women: findings from the China Kadoorie Biobank. BMC Med (2017) 0.75
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science (1999) 8.43
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol (1991) 2.35
Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities? Gynecol Oncol (1998) 2.03
Endometrial receptivity: the age-related decline in pregnancy rates and the effect of ovarian function. Fertil Steril (1993) 2.02
Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med (1984) 1.92
Interaction between warfarin sodium and amiodarone. N Engl J Med (1981) 1.88
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 1.79
Laparoscopic accessory splenectomy for recurrent idiopathic thrombocytopenic purpura and hemolytic anemia. Surg Endosc (2000) 1.61
Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul (1990) 1.55
Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod (1994) 1.53
Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol (1994) 1.48
Combined colposcopy, loop conization, and laser vaporization reduces recurrent abnormal cytology and residual disease in cervical dysplasia. Gynecol Oncol (2000) 1.46
Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Prenat Diagn (1996) 1.44
Brief report: lymphoma with recurrent cycles of spontaneous remission and relapse--possible role of apoptosis. N Engl J Med (1995) 1.42
Stress urinary incontinence: prevalence among nulliparous compared with primiparous and grand multiparous premenopausal women. Neurourol Urodyn (1999) 1.42
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation. Cancer (1992) 1.42
Feto-feto-fetal transfusion syndrome in monozygotic monochorionic triamniotic triplets: vascular evaluation by a cast model. Placenta (2005) 1.40
Uterine rupture with the use of a low-dose vaginal PGE2 tablet. Acta Obstet Gynecol Scand (1993) 1.40
Superior vena cava occlusion in a patient with antiphospholipid antibody syndrome. J Rheumatol (1991) 1.40
Timing of sonohysterography in menstruating women. Gynecol Obstet Invest (1999) 1.39
Interferon-alpha-2b with VMCP for induction in multiple myeloma: the Israel Myeloma Cooperative Group experience. Isr J Med Sci (1995) 1.38
Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem (1999) 1.35
Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res (1989) 1.33
Analysis of 104 twin pregnancies conceived with assisted reproductive technologies and 193 spontaneously conceived twin pregnancies. Fertil Steril (2000) 1.27
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood (1987) 1.26
Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: nonenzymatic mode of action. Cell Regul (1990) 1.22
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
Avian hemangioma retrovirus induces cell proliferation via the envelope (env) gene. Virology (2000) 1.19
Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology (1999) 1.18
Genetic evaluation of infertile men. Hum Reprod (1999) 1.17
Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost (1987) 1.17
Combined genitourinary prolapse repair and prophylactic tension-free vaginal tape in women with severe prolapse and occult stress urinary incontinence: preliminary results. Urology (2001) 1.14
Prediction of haemorrhagic diathesis in thrombocytopenia by mean platelet volume. Br Med J (Clin Res Ed) (1982) 1.13
Treatment of dermatomyositis with methotrexate. Lancet (1968) 1.11
Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells. J Clin Invest (1981) 1.11
Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol (2001) 1.10
Intramural pregnancy with fetal survival: case history and discussion of etiologic factors. Obstet Gynecol (1987) 1.09
The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction. J Urol (2000) 1.09
Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum (2001) 1.08
High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med (1987) 1.07
The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Studies with vascular smooth muscle cells and endothelial cells. Exp Cell Res (1985) 1.06
Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. J Clin Invest (1989) 1.06
The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer (2003) 1.04
Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol (1997) 1.03
Anal incontinence: prevalence among female patients attending a urogynecologic clinic. Neurourol Urodyn (1999) 1.03
Merkel cell tumor in a woman with chronic lymphocytic leukemia. Leuk Lymphoma (1996) 1.02
In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol (1997) 1.02
Enhanced aggregability of red blood cells of beta-thalassemia major patients. Am J Physiol (1996) 1.02
Testicular cancer and spermatogenesis. Hum Reprod (1997) 1.02
Antenatal sonographic diagnosis of epignathus at 15 weeks of pregnancy. Ultrasound Obstet Gynecol (1999) 1.02
Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. Arterioscler Thromb Vasc Biol (1999) 1.01
Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol (2001) 1.00
Intracranial hemorrhage in patients with hemophilia. Neurosurgery (1986) 1.00
On the mechanism of immunological tolerance in cyclophosphamide-treated mice. Clin Exp Immunol (1970) 1.00
Platelet interaction with the extracellular matrix produced by cultured endothelial cells: a model to study the thrombogenicity of isolated subendothelial basal lamina. Thromb Res (1982) 1.00
Klippel-Trénaunay-Weber syndrome associated with fetal growth restriction. Hum Reprod (1996) 1.00
The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril (1996) 1.00
Nifedipine versus ritodrine for suppression of preterm labour. Br J Obstet Gynaecol (1993) 0.99
Retrograde ejaculation. Hum Reprod (1994) 0.98
The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost (1984) 0.97
Testicular sperm retrieval and cryopreservation prior to initiating ovarian stimulation as the first line approach in patients with non-obstructive azoospermia. Hum Reprod (1999) 0.96
Persistent right umbilical vein: incidence and significance. Ultrasound Obstet Gynecol (2002) 0.96
Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol (1993) 0.96
Pemphigus vulgaris in pregnancy: a case report and review of literature. Hum Reprod (2000) 0.96
The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients. Clin Exp Immunol (1978) 0.96
Multiple testicular sampling in non-obstructive azoospermia--is it necessary? Hum Reprod (1998) 0.96
Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. J Clin Invest (1984) 0.96
Role of urethrocystoscopy in the evaluation of refractory idiopathic detrusor instability. Urology (2001) 0.96
Pheochromocytoma in pregnancy: case report and review of the literature. Obstet Gynecol Surv (1995) 0.95
Free radicals, antioxidants and human spermatozoa: clinical implications. Hum Reprod (1998) 0.95
Risk factors for severe perineal injury during childbirth: a case-control study of 60 consecutive cases. Colorectal Dis (2011) 0.94
Leptin attenuates follicular apoptosis and accelerates the onset of puberty in immature rats. Mol Cell Endocrinol (2001) 0.94
Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker? Fertil Steril (1999) 0.94
Heredity and coagulation studies in ten families with Factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol (1965) 0.94
Spindle imaging: a new marker for optimal timing of ICSI? Hum Reprod (2004) 0.94
Typhoid fever complicating pregnancy. Acta Obstet Gynecol Scand (1985) 0.94
Aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum (1996) 0.94
Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages. Arterioscler Thromb Vasc Biol (1999) 0.94
Ectopic pregnancy after in vitro fertilization-embryo transfer (IVF-ET): the possible role of the ET technique. J Assist Reprod Genet (1993) 0.93
The classic approach to diagnosis of vulvovaginitis: a critical analysis. Infect Dis Obstet Gynecol (2001) 0.93
Vaginal injury resulting from sliding down a water chute. Am J Obstet Gynecol (1992) 0.93
High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand (2000) 0.93
A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood (1997) 0.93
Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol (1998) 0.92
Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix. Blood (1990) 0.92
Cytocidal effect caused by the envelope glycoprotein of a newly isolated avian hemangioma-inducing retrovirus. J Virol (1989) 0.92